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VASCULAR BIOLOGY
The interplay between the Rab27A effectors Slp4-a and MyRIP controls
hormone-evoked Weibel-Palade body exocytosis
*Ruben Bierings,1 *Nicola Hellen,1 Nikolai Kiskin,1 Laura Knipe,1 Ana-Violeta Fonseca,1 Bijal Patel,1 Athina Meli,2
Marlene Rose,2 Matthew J. Hannah,1 and Tom Carter1
1Medical Research Council National Institute for Medical Research, The Ridgeway, London, United Kingdom; and 2Faculty of Medicine, Imperial College
London, London, United Kingdom
Weibel-Palade body (WPB) exocytosis un-
derlies hormone-evoked VWF secretion
from endothelial cells (ECs). We identify
new endogenous components of the
WPB: Rab3B, Rab3D, and the Rab27A/
Rab3 effector Slp4-a (granuphilin), and
determine their role in WPB exocytosis.
We show that Rab3B, Rab3D, and Rab27A
contribute to Slp4-a localization to WPBs.
siRNA knockdown of Slp4-a, MyRIP,
Rab3B, Rab3D, Rab27A, or Rab3B/
Rab27A, or overexpression of EGFP-
Slp4-a or EGFP-MyRIP showed that Slp4-a
is a positive and MyRIP a negative regula-
tor of WPB exocytosis and that Rab27A
alone mediates these effects. We found
that ECs maintain a constant amount of
cellular Rab27A irrespective of the WPB
pool size and that Rab27A (and Rab3s)
cycle between WPBs and a cytosolic pool.
The dynamic redistribution of Rab pro-
teins markedly decreased the Rab27A
concentration on individual WPBs with
increasing WPB number per cell. Despite
this, the probability of WPB release was
independent of WPB pool size showing
that WPB exocytosis is not determined
simply by the absolute amount of Rab27A
and its effectors on WPBs. Instead, we
propose that the probability of release is
determined by the fractional occupancy
of WPB-Rab27A by Slp4-a and MyRIP,
with the balance favoring exocytosis.
(Blood. 2012;120(13):2757-2767)
Introduction
Hormone-evoked VWF secretion from endothelial cells (ECs) is
mediated by exocytosis of specialized secretory granules (SGs)
called Weibel-Palade bodies (WPBs).1 WPB exocytosis is triggered
by increases in intracellular free Ca2 or cAMP concentrations, and
involves a number of molecular components, including the N-
ethylmaleimide–sensitive factor, VAMP3, SNAP23, syntaxin 4,
RalA, the annexin A2/S100A10 complex, and phospholipase D.2-7
In addition, Rab proteins also regulate WPB exocytosis. A
subset of Rab proteins, including Rab3A-3D, Rab27A/B, and
Rab37, is associated with SGs in different cell types where they
regulate SG biogenesis, trafficking, and exocytosis.8 Secretory
cells often express a mixture of these “secretory” Rabs, which may
have overlapping or distinct functions. Human ECs are reported to
express mRNA for Rab3A, Rab3D, and Rab37,3,9,10 Rab3B pro-
tein,11 and Rab27A mRNA and protein.12,13 To date, Rab27A is the
only endogenous EC Rab protein that has been detected on WPBs.
Through its effector MyRIP and Myosin Va, Rab27A is proposed to
negatively regulate WPB exocytosis.13,14 Rab27A can interact with
different effector molecules, and many secretory cells express a
mixture of these effectors.8 In these cases, SG exocytosis probably
depends on the balance of Rab27A interactions with the comple-
ment of Rab effectors in the cell.
In addition to MyRIP, ECs contain mRNA for the Rab27A
effector Slp4-a (granuphilin).13 Slp4-a links SGs to the plasma
membrane (PM) through SG-associated Rab proteins (principally
Rab27A), PM-associated syntaxins (1a, 2, or 3) and soluble
Munc18 isoforms.15-19 Syntaxins exist in open and closed conforma-
tions that determine their participation in SNARE complex forma-
tion and membrane fusion. Slp4-a binds the closed conformation of
syntaxin,16,19 which selectively interacts with Munc18 proteins to
hold SGs in a fusion-incompetent state at the PM. Overexpression
of Slp4-a increased numbers of PM-docked SGs but inhibited
secretion, whereas knockout or knockdown (KD) studies showed
the opposite.20 Unlike MyRIP, Slp4-a interacts with several differ-
ent Rab proteins, including Rab3A-3D and Rab8,15,21 and with
myosin Va,22 a point of convergence with MyRIP.
In this study, we identified Slp4-a, Rab3B, and Rab3D as new
components of WPBs and investigated their roles in regulating
hormone-evoked WPB exocytosis and VWF secretion. We found
that, in contrast to other secretory cells, Slp4-a acts as a positive
regulator of WPB exocytosis, and its interplay with the negative
regulator MyRIP on Rab27A bound to WPBs (WPB-Rab27A) sets
the probability of WPB exocytosis.
Methods
Tissue culture, transfection, secretion assays, antibodies, DNA
constructs, and reagents
Primary HUVECs were purchased, cultured and transfected as previously
described.23 Human aortic endothelial cells (HAECs) were cultured as
previously described.24 Secreted VWF and EGFP were assayed by ELISA
as previously described.25 Primary antibodies (Abs) along with the dilutions
for immunofluorescence and Western blotting are given in supplemental
Table 1A (available on the Blood Web site; see the Supplemental Materials
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link at the top of the online article) with sources of secondary Abs
appended. Production of an anti-Rab27A Ab is described in supplemental
Figure 1A. DNA constructs are described in the supplemental Appendix 1.
Primers for amplification of full-length Rab3 isoforms, MyRIP and Slp4-a,
are listed in supplemental Table 1B. All reagents were from Sigma-Aldrich
unless otherwise stated. Fura-2/AM was from Invitrogen.
Immunoblotting
Cells were rinsed with PBS and lysed in 2 sample buffer12 containing
-mercaptoethanol and protease inhibitors (Sigma-Aldrich: P8340) or in
PBS containing 1% Triton X-114, 2mM EDTA, and protease inhibitors. To
concentrate hydrophobic proteins, Triton X-114 partitioning of the lysate
was performed as described.12 Protein in the detergent phase was precipi-
tated with methanol-chloroform using 0.25 g BSA as carrier. Proteins
were separated on a 12% SDS-PAGE gel, transferred to 0.2 m nitrocellu-
lose membrane, and probed with primary Ab, followed by infrared
dye-coupled secondaries. Membranes were scanned with the LI-COR
Odyssey Infrared Imaging system (LI-COR Biosciences).
RNAi
Pools of 4 siRNA oligo duplexes (ON-TARGETplus SMARTpool, Dharma-
con RNA Technologies) were used to deplete HUVECs of the mRNAs of
Rab27A (#L004667), Rab3B (#L008825), Rab3D (#L010822), Slp4-a
(#L007111), and MyRIP (#L013964). Oligo sequences are in supplemental
Table 1C. A pool of 4 nontargeting siRNAs (ON-TARGETplus Non-
targeting pool, #D001810) was used as a control (siCTRL). A total of
1000 pmol of siRNA duplexes was transfected by nucleofection into
7.5  106 HUVECs. ECs were plated at confluent density ( 0.8  105
cells/cm2) in gelatin-coated wells of 6- or 12-well plates or on gelatin-
coated glass coverslips and cultured in HUVEC growth medium for
48 hours. Depletion of Rab27A, Rab3B, Rab3D, Slp4-a, and MyRIP was
assessed by quantitative PCR, immunocytochemistry, or immunoblotting.
RT-PCR and quantitative PCR analysis
RNA was extracted using RNeasy Mini Kit (QIAGEN) and integrity
verified on a 2100 Bioanalyzer (Agilent Technologies). cDNA was synthe-
sized using a QuantiTect Reverse Transcription kit (QIAGEN) from 500 ng
of RNA. RT-PCR primers for Rab3A to Rab3D are in supplemental Table
1D. The cycling protocol was: initial 95°C for 30 seconds followed by
30 cycles of 95°C for 15 seconds, 52°C for 30 seconds, 68°C for 15 seconds, final
5 minutes at 72°C and products run on 2% agarose gel. Alternative primers and
cycling conditions for Rab3A were also used.9 Quantitative PCR primers for
reference genes (RGs: ACTB, GAPDH, B2M, UBC, YWHAZ, SF3A1, CYC1,
EIF4A2, SDHA [housekeeping gene detection kit]), Rab27A, Slp4-a, MyRIP,
Rab3B, and Rab3D were designed and synthesized by PrimerDesign LTD
(supplemental Table 1D). Amplification was detected using Sensimix (Bioline)
and analyzed on a Rotor-gene 6000 (Corbett Life Science) using 95°C for
10 minutes, then 40-45 cycles of 10 seconds at 95°C, 15 seconds at 60°C, and
20 seconds at 72°C, followed by a 5-minute melt sequence to verify single
amplicons. Single products were further verified on 2% agarose gels and
extracted (GenElute gel extraction kit) for standard curve generation. Absolute
copy number was determined and normalized to-actin (ACTB) expression. For
KD experiments, cDNA samples were first screened for RG expression levels,
and geNorm Version 3.4 software (PrimerDesign LTD) was used to determine
normalization factors before normalization. Quantification was calculated using
theCT method.26
Immunocytochemistry and quantification of antigen
immunoreactivity on WPBs
Immunostaining and imaging of fixed cells were performed as previously
described.25 For both confocal (40 objective) and wide-field (100
objective) intensity measurements, exposures at each wavelength were first
set to ensure no detector saturation on the brightest sample and then kept
constant for all images. Images were processed in ImageJ (http://
rsbweb.nih.gov/ij/) and numbers of WPBs quantified as previously de-
scribed.25 Mean WPB fluorescence intensities (FIs) for endogenous Rab27A,
MyRIP, Slp4-a, Rab3B immunoreactivity (IR) or for EGFP-Rab27A,
-MyRIP or -Slp4-a were determined from background-subtracted regions of
interest (ROI) enclosing individual WPBs. Two (Slp4-a, MyRIP) or
3 (Rab27A) independent experiments were performed using 6-12 (confocal)
or 50 (wide-field) fields of view in which 12 WPBs/per cell were analyzed
in cells from a minimum of 10 (confocal) or 1 or 2 (wide-field) cells.
Live cell imaging
Exocytosis of Proregion-EGFP-containing WPBs was determined as previ-
ously described.23,25 The moment of WPB fusion for EGFP-Rab27A– or
EGFP-Slp4-a–expressing cells was determined by an abrupt decrease in
WPB fluorescence on fusion (illustrated for Rab27A in supplemental Figure
1B). The probability of WPB exocytosis, Pr, was determined as the mean
percentage of degranulation of fluorescent WPBs after cell stimulation. The
mean WPB-EGFP FI for EGFP-Rab27A was determined as described in
“Immunocytochemistry and quantification of antigen immunoreactivity on
WPBs.” Rab acquisition by immature WPBs was determined by time-lapse
imaging of ECs expressing VWF-tdTomato (VWF-tdT) and EGFP-Rab27A
or mEGFP-Rab3B (16 hours after nucleofection). Microscope and experi-
mental details are in the legend to supplemental Video 1. Mean WPB-EGFP
and WPB-tdT FIs were determined from background-subtracted images as
described in the previous section.
Whole-WPB fluorescence recovery analysis of Rabs and
effectors cycling on WPBs
Leica TCS SP2 or Leica TCS SP5 confocal microscopes equipped with PL
APO 100  0.7-1.4NA (SP2) or HCX PL APO CS 100  1.46NA (SP5)
objectives were used to study fluorescence recovery after whole WPB
bleaching (FRAP) at 37°C. Imaging and bleaching settings were as
previously described.27 For FRAP, 1-2 pulses at full laser power were
applied to a bleaching ROI encompassing the entire WPB, and the WPB FI
followed to monitor recovery. For whole-cell inverse FRAP (iFRAP28) a PL
APO 63  0.6-1.4NA objective was used to image at least 2 fluorescent
cells at a time. All but a small region of 1 cell (containing a few WPBs) was
bleached using full laser power pulses at 1- to 2-second intervals over
an  5-minute period. The decline in FI in the unbleached region of the test
cell was followed at 1- to 10-minute intervals. For analysis, ROIs were
defined by thresholding low-pass filtered images above the background to
include just the bleached WPB (FRAP) or unbleached (iFRAP) WPBs in
the cell. The average FI within the ROIs was scaled by the decline because
of bleaching in adjacent unbleached control cells/WPBs in the image.
Exponential fitting was performed in Origin Version 8.5 (OriginLab)
without constraints on offset or final level.
Statistical analysis
Data were plotted in Origin Version 7.5 or greater or GraphPad Prism
Version 5.0. Statistical analysis was by nonparametric t test (except where
indicated) using GraphPad Prism Version 5.0. Significance values are
shown on the figures or in figure legends. Data are shown as mean  SEM.
Results
Slp4-a is localized to WPBs
Identification of Slp4-a mRNA in HUVECs13 led us to examine
whether this Rab27A effector was associated with WPBs and
played a role in regulating WPB exocytosis. Endogenous Slp4-a-IR
was readily detectable on WPBs in HUVECs (Figure 1A; supple-
mental Figure 2A) and adult HAECs (supplemental Figure 2B).
Furthermore, expression of EGFP-Slp4-a specifically labeled WPBs
(eg, see Figure 4Ci). However, several observations indicate that
Rab27A is not solely responsible for recruiting Slp4-a to WPBs.
First, HUVECs with few WPBs (eg, * in Figure 1B) consistently
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had strong WPB-Rab27A-IR, whereas HUVECs with large num-
bers of WPBs (**) had almost undetectable WPB-Rab27A-IR (see
also supplemental Figure 3A-B; quantified in Figure 6A). Control
experiments showed the intensity of WPB-Rab27A-IR was propor-
tional to WPB-Rab27A-antigen concentration (supplemental Fig-
ure 3C), so the reduction in WPB-Rab27A-IR reflects a reduction
in WPB-Rab27A concentration. This pattern was mirrored by
endogenous WPB-MyRIP-IR but not by WPB-Slp4-a-IR, which
remained prominent irrespective of WPB number, and the same
was seen in HAECs (Figure 1B; supplemental Figures 2 and 3B,D).
Second, KD of Rab27A in HUVECs resulted in loss of both
WPB-Rab27A- and WPB-MyRIP-IR, but not of WPB-Slp4-a-IR
(supplemental Figure 3E). Finally, we observed a subpopulation of
Rab27A-negative WPBs displaying Slp4-a-IR (Figure 2D). Be-
cause Slp4-a can also bind Rab8 and Rab3A-3D15,21 (and supple-
mental Figure 4A), we next looked for the expression and WPB
localization of these Rab proteins. Although HUVECs express
Rab8,11,29 we detected neither endogenous nor epitope-tagged Rab8
Figure 1. Endogenous Slp4-a, Rab3B, and Rab3D are ex-
pressed in HUVECs and localize to WPBs. (A) HUVECs
immunolabeled for endogenous VWF (red) and Slp4-a (green).
The intensity levels of the red (VWF) channel were adjusted from
0-255 to 0-130 intensity units. Scale bar represents 200 m.
Grayscale images are from the region indicated by the white box
(scale bar represents 20 m). (B) Left: HUVECs immunolabeled
for endogenous Rab27A (red), Slp4-a (green), and MyRIP (blue).
Scale bar represents 20 m. Dashed white lines indicate approxi-
mate cell boundaries and a cell with few (*) and a cell with many
(**) WPBs are indicated. Right top: Grayscale images are shown
for each channel as indicated and the subregions i and ii shown
on expanded scales below. (C) HUVECs immunolabeled for
endogenous Rab3B (mouse Ab, green) or Rab3D (mouse Ab,
green) and VWF (rabbit Ab, red). Top: Endogenous Rab3B-IR is
localized to WPBs. Middle:  95% of cells had no WPB-
Rab3D-IR (see also supplemental Figure 4Civ). Bottom: 	 5% of
cells had weak WPB-Rab3D-IR (arrowheads). Scale bars repre-
sent 10 m. Immunofluorescence images of fixed cells here and
in all subsequent figures were taken at room temperature using
Leica SP1 or SP2 confocal microscopes and software (Version
2.61, build 1537) equipped with 40 and 100 objectives (SP1;
PL APO40  1.25-0.75NA, PL APO100  1.4NA, SP2; HCX PL
APO40  1.2 NA, PL APO100  1.4NA).
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on WPBs. We therefore focused on Rab3 isoforms (specificities of
the Rab3 reagents are shown in supplemental Figure 4Bi-vi).
Rab3B and Rab3D are expressed in ECs and localized to WPBs
Expression of mEGFP-Rab3A-3D labeled WPBs in HUVECs
(supplemental Figure 4Bii-vi); however, immunostaining showed
that only endogenous Rab3B-IR was clearly detectable on WPBs in
HUVECs (and HAECs), whereas WPB-Rab3D-IR was weakly
detectable in only  5% of cells (Figure 1C; supplemental Figure
4C-D). RT-PCR and Western blot analysis confirmed that only
Rab3B and Rab3D were expressed in HUVECs (supplemental
Figure 4E). No Rab3A mRNA was found despite using primers and
conditions reported to detect this Rab in HUVECs9 (supplemental
Figure 4E). Quantitative PCR quantification showed that Rab3B
and Rab3D transcripts together were  10 times more abundant
than Rab27A transcripts.
Unlike WPB-Rab27A-IR, WPB-Rab3B-IR was clearly ob-
served irrespective of WPB pool size and matched closely the
pattern for endogenous Slp4-a-IR (Figure 2A). Similar to Rab27A,12
Rab3B-IR was absent from most newly formed WPBs at the
trans-Golgi network (Figure 2B); however, we observed a subpopu-
lation of immature Rab27A-negative WPBs that were Rab3B-
positive (Figure 2C) and displayed clear Slp4-a-IR (Figure 2D).
Together, the data show that Rab27A is not the sole Slp4-a-
interacting Rab protein on WPBs and that the WPB localization of
Rab3B matches closely that of Slp4-a.
Rab3B is recruited slowly to immature WPBs but cycles rapidly
on mature WPBs where it recruits Slp4-a
Because differences in the kinetics of recruitment of Rab3B and
Rab27A to immature WPBs might account for Rab3B-IR on
perinuclear Rab27A-negative WPBs, we next determined the time
constants of recruitment (
recr) of mEGFP-Rab3B and EGFP-
Rab27A to immature VWF-tdT–expressing WPBs in live cells (eg,
supplemental Video 1). 
recr for mEGFP-Rab3B and EGFP-
Rab27A were not significantly different (Figure 3A), indicating
that other factors may account for this phenomenon (see
“Discussion”).
To investigate whether Rab3B or Rab3D might contribute to
WPB recruitment of Slp4-a, we performed WPB bleaching experi-
ments. The rationale for FRAP experiments was that Rab proteins
and their effectors exchange (cycle) between their target mem-
branes and the cytosol, and that this process, for both Rabs and
effectors, is linked to the Rab GTP-GDP cycle.30 Where an effector
(Slp4-a) has access to a mixture of different Rabs, as is potentially
the case here, the cycling kinetics will reflect a composite function
of the kinetics of the individual Rabs of the mixture. Thus, by
determining the association time constants (
ass) for individual
WPB-Rabs and comparing 
ass for Slp4-a cycling on WPBs
expressing exogenous Rab27A, Rab3B, or Rab3D with Slp4-a
cycling in the absence of expressed WPB-Rabs, we might identify
with which WPB-Rab Slp4-a interacts.
We quantified 
ass for EGFP-tagged Rab27A, Rab3B, or Rab3D
after whole WPB bleaching. EGFP-Rab27A recovered very slowly
and often incompletely during the observation period (Figure 3B).
mRFP-Rab27A behaved like EGFP-Rab27A. mEGFP-Rab3B and
-Rab3D recovered significantly faster than EGFP-Rab27A (Figure
3B,D). Dissociation time constants (
diss) for EGFP-Rabs, deter-
mined by iFRAP, were of similar magnitude to 
ass (Figure 3B-C),
both probably reflecting the off-rates of Rab unbinding from the
WPB.31 For mEGFP-Rab3B, both 
ass and 
diss were significantly
faster than for EGFP-Rab27A.

ass for EGFP-Slp4a to WPBs coexpressing exogenous mRFP-
tagged Rab27A, Rab3B, or Rab3D were, in each case, similar to
those of the Rab protein alone (Figure 3D-E). Notably, EGFP-
Slp4-a when expressed alone recovered fast, with a 
ass similar to
that seen in the presence of exogenous Rab3B (or Rab3D; Figure
Figure 2. Rab3B is detectable on WPBs before
Rab27A and colocalizes with Slp4-a. (A) HUVECs
immunolabeled for endogenous Rab3B (mouse Ab,
green), Slp4-a (rabbit Ab, red), and VWF (sheep Ab,
blue). Here and in other figures, grayscale images are
from regions indicated by white boxes. (B) HUVECs
expressing Proregion-EGFP (Pro-EGFP, green, 24 hours
after nucleofection) immunolabeled for endogenous
Rab3B (mouse Ab, red). Grayscale images represent
regions with perinuclear immature (right) or peripheral
mature WPBs (bottom). (C) HUVECs immunolabeled for
Rab3B (mouse Ab, red), Rab27A (rabbit Ab, green), and
VWF (sheep Ab, blue). Insets: right, arrowheads point to
Rab3B-positive, Rab27A-negative perinuclear immature
WPBs; bottom, Rab3B- and Rab27A-positive mature
WPBs. (D) HUVECs immunolabeled for Rab3B (goat Ab;
red), Rab27A (mouse Ab, green), and Slp4-a (rabbit Ab,
blue). Inset: right, Rab3B-positive, Rab27A-negative,
Slp4-a-positve perinuclear immature WPBs; bottom, ma-
ture WPBs positive for all markers. Scale bars represent
10 m.
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3E). This indicates that Slp4-a can interact with endogenous Rab3B
and/or Rab3D on WPBs.
Analysis of Slp4-a, MyRIP, and WPB-Rab function in WPB
exocytosis
Slp4-a is a positive and MyRIP a negative regulator of WPB
exocytosis. To assess the function of Slp4-a in hormone-evoked
WPB exocytosis, we depleted endogenous Slp4-a by siRNA KD
and for comparison analyzed the effect of MyRIP KD. Slp4-a KD
(Figure 4A) substantially decreased while MyRIP KD (Figure 4B)
increased histamine-evoked VWF secretion. To examine the effect
of overexpression of EGFP-Slp4-a or EGFP-MyRIP on Ca2-
driven WPB exocytosis, we performed live cell experiments. Both
constructs labeled all WPBs, with the exception of immature
organelles at the trans-Golgi network (Figure 4Ci). Figure 4Cii-iii
compares the kinetics and extent of WPB exocytosis in control
cells expressing the WPB-specific protein Proregion-EGFP23 (black)
with that in EGFP-Slp4-a–expressing cells (red). Cumulative plots
of WPB fusion events (Figure 4Cii bottom) are aligned to the
increase in intracellular Ca2 (top in Figure 4Cii). The mean delay,
maximal rate, and probability of WPB fusion (Pr), are summarized
in Figure 4Ciii. In EGFP-Slp4-a–expressing cells, WPB exocytosis
was initially slowed, although later the rate increased and reached
control values in Proregion-EGFP cells. Surprisingly, Pr was
significantly increased (Figure 4Ciii). In marked contrast, expres-
sion of EGFP-MyRIP completely blocked Ca2-driven WPB
exocytosis.
Quantification of the intensity of endogenous WPB-MyRIP-IR
as a function of the FI of WPB-EGFP-Slp4-a showed that
overexpression of EGFP-Slp4-a reduced endogenous WPB-
MyRIP-IR (Figure 4Civ black symbols). In contrast, EGFP-MyRIP
overexpression had only a small effect on endogenous WPB-Slp4-
a-IR (Figure 4Civ gray symbols), presumably because Slp4-a,
unlike MyRIP, interacts with GTP-Rab3B, GTP-Rab3D, and
GDP-Rab27A on WPBs. The data show that Slp4-a and MyRIP
exert opposing effects on WPB exocytosis and VWF secretion and
that Slp4-a competes with MyRIP for its WPB-specific binding
partner Rab27A.
Rab27A, but not Rab3B or Rab3D, regulates VWF secretion.
Having established that Slp4-a acts as a positive regulator of
histamine-evoked VWF secretion and that it can interact with
WPB-Rab3s, we next determined the relative contributions of
Rab3B, Rab3D, and Rab27A to hormone-evoked VWF secretion.
To do this, we performed KDs of each Rab individually and of
Rab27A and Rab3B together (Figure 5). KDs profoundly depleted
each Rab, with endogenous WPB-Rab3B- and WPB-Rab27A-IR
Figure 3. Rab recruitment to and cycling on WPBs:
evidence for association of EGFP-Slp4-a with Rab3s
on mature WPBs. (A) Left: Images from time-lapse
videos showing Rab acquisition by immature VWF-tdT
containing WPBs in HUVECs coexpressing either
mEGFP-Rab3B (top) or EGFP-Rab27A (bottom). Times are
indicated below the panels. Right: Example time courses of
mEGFP-Rab3B (E, 
recr 709 seconds) or EGFP-Rab27A (Œ,

recr 1070 seconds) recruitment to VWF-tdT–labeled WPBs.
Bar plot represents the mean values of 
recr for WPB-mEGFP-
Rab3B (1730 355 seconds, n 7) and WPB-EGFP-
Rab27A (2260 365 seconds, n 9) were not significantly
different (P .35). (B) Left: Images from FRAP experiments
with WPB-EGFP-Rab27A (top; scale bar represents 2 m)
and WPB-mEGFP-Rab3B (bottom; scale bar represents
1 m) show FI recovery after complete WPB bleaching
(FRAP, t 0 seconds). Times are indicated below frames.
Right: Average WPB mEGFP-Rab3B (E) and EGFP-
Rab27A (Œ) FIs normalized to the prebleach levels. Graphs
were fitted with exponential association functions
A [1 exp(t/
ass)]. Unconstrained fits to fluorescence
recovery reached 0.80 for Rab3B and 0.63 for Rab27A.
(C) Left: Images from iFRAP experiments with EGFP-
Rab27A (top) and mEGFP-Rab3B (bottom). Scale bars
represent 10 m. Regions indicated by boxes were continu-
ously bleached for 5 minutes, then FI of unbleached WPBs
was measured. Fluorescence of neighboring cells was used
for control. Times after bleaching are indicated below frames.
Right: Average FIs of WPB-mEGFP-Rab3B (E) and WPB-
EGFP-Rab27A (Œ) were normalized to the initial postbleach
levels. Graphs were fitted with exponential decay functions
A  exp(t/
diss). (D) Average cycling time constants
determined for each EGFP-Rab by FRAP (
ass, gray)
and iFRAP (
diss, white) were as follows: EGFP-
Rab27A, 1970  550 seconds (n  8) and 4020 1090
seconds (n 6); mEGFP-Rab3B, 196 18 seconds (n 6)
and 468 211 seconds (n 5); mEGFP-Rab3D, 496 79
seconds (n 8) and 1300 296 seconds (n 8), respec-
tively. The 
ass (FRAP) for mEGFP-Rab3B and Rab3D were
significantly faster than for EGFP-Rab27A (P .0007 and
P .002, respectively). The 
diss (iFRAP) for mEGFP-
Rab3B was also significantly faster than for EGFP-Rab27A
(P .017). (E) Average 
ass for EGFP-Slp4-a coexpressed
with RFP-tagged Rab27A (n 8), Rab3B (n 7), Rab3D
(n 8), or alone (n 14) as indicated. 
ass for EGFP-Slp4-a
coexpressed with Rab3B or Rab3D were not different from
that for EGFP-Slp4-a alone (P .31 and P .43, respec-
tively), whereas they were significantly faster than 
ass with
mRFP-Rab27Acoexpression.
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greatly diminished in both single and double KDs (Figure 5Ai-iii).
KD of Rab27A also depleted WPB-MyRIP- but not WPB-Slp4-
a-IR (supplemental Figure 3E). Substantial depletion of WPB-Slp4-
a-IR was observed only after Rab3B/Rab27A double KD (Figure
5Aiv), and not after Rab3B or Rab27A KDs (supplemental Figures
3Eii and 5).
KD of Rab27A, but not of Rab3B or Rab3D, significantly
reduced histamine-evoked VWF secretion (Figure 5Bi-ii), and no
further significant decrease was seen after Rab3B/Rab27A KD.
Together, the data show that Rab27A and not Rab3B or Rab3D
regulate histamine-evoked VWF secretion and suggest that the
influence on exocytosis of their common effector, Slp4-a, is
mediated via Rab27A alone.
The probability of WPB exocytosis is unaffected by reductions
in WPB-Rab27A concentration with increasing WPB pool size.
The inhibition of histamine-evoked VWF secretion by Rab27A KD
led us to ask whether the natural reduction in WPB-Rab27A
concentration with increasing WPB pool size (Figure 1B; supple-
mental Figure 3) was mirrored by a decrease in Pr. The reduction in
WPB-Rab27A concentration with increasing WPB pool size is
summarized in Figure 6A (along with the corresponding variation
in WPB-MyRIP and WPB-Slp4-a levels). As the same relationship
was seen in Proregion-EGFP–expressing HUVECs (supplemental
Figure 6A), we could assess directly how Pr varied with WPB pool
size in live cells. Figure 6B shows Pr as a function of the mean
number of fluorescent WPBs per cell in the same ranges as in
Figure 6A. Cells were stimulated with low or high concentrations
of histamine or a maximally effective concentration of ionomycin.
In each case, Pr was independent of WPB pool size. We next
addressed the cellular mechanism for the reduction in WPB-
Rab27A levels with increased WPB pool size.
We hypothesized that, if total cellular Rab27A levels remain
unchanged with increasing WPB numbers, then Rab27A cycling
between WPBs would account for the dilution in WPB-Rab27A
concentration. To test this hypothesis, we took advantage of the fact
that VWF content and WPB numbers in HUVECs increase with
time in culture.32 We determined how cellular levels of the
WPB-specific marker Proregion and of Rab27A change with time
Figure 4. Slp4-a and MyRIP have opposing effects on
WPB exocytosis and VWF secretion. Quantification of
mRNA for Slp4-a (Ai) and MyRIP (Bi) after nucleofection
with either control (siCTRL) or specific KD oligos as
indicated. mRNA was depleted by 65%  3% (Ai) or
67%  3% (Bi) in KD compared with control. Data were
pooled from 3 independent experiments. (Aii,Bii) Immuno-
blots for Slp4-a or MyRIP, respectively, after nucleofec-
tion with either control (siCTRL) or specific KD oligos as
indicated. Data are representative of 3 independent
experiments. Position of molecular weight markers (kDa)
are shown to the left and -tubulin used as loading
control. (Aiii,Biii) Immunostaining of HUVECs for Slp4-a
(rabbit Ab, green) and VWF (sheep Ab, red; Aiii) or MyRIP
(goat Ab; green) and VWF (rabbit Ab, red; Biii) in control
or after KD as indicated. Scale bars represent 10 m.
(Aiv,Biv) Histamine-evoked VWF secretion, quantified by
ELISA, from HUVECs nucleofected with control, Slp4-a
(Aiv) or MyRIP (Biv) siRNA oligos as indicated. White and
gray bars represent unstimulated (vehicle alone) and
histamine-stimulated conditions, respectively. Data were
pooled from 3 independent experiments. A small but
significant decrease in basal release was seen with
Slp4-a KD (siCTRL, 0.9%  0.08% vs siSlp4-a,
0.57%  0.1% of total VWF, P  .01) and a trend to an
increase in basal secretion for MyRIP KD (siCTRL,
0.27%  0.07% vs siMyRIP, 0.43%  0.15% of total
VWF), although the latter did not reach significance
(P  .4). (Ci) HUVECs expressing EGFP-Slp4-a (top,
green) or EGFP-MyRIP (bottom, green) 24 hours after
nucleofection and immunolabeled for VWF (sheep Ab;
red). Grayscale images are from regions indicated by
white boxes. Scale bars represent 20 m. (Cii). Top:
Fura-2 fluorescence ratio showing intracellular Ca2 rise.
Bottom: Cumulative plot of WPB fusion event times,
normalized by their total number, in Proregion-EGFP-
(black, 46 cells, 2151 fusion events), EGFP-Slp4-a– (red,
15 cells, 849 fusion events), and EGFP-MyRIP–express-
ing cells (blue, 21 cells, total absence of fusion events).
Inset: The initial period after stimulation on an expanded
time scale. (Ciii) Mean delays (seconds), maximal rates
of exocytosis (WPBs/second), and probabilities of WPB
exocytosis, Pr, (percent, note broken Y scale) for
Proregion-EGFP (black) or EGFP-Slp4-a–expressing cells
(red). (Civ) Relationship between the average intensity of
endogenous WPB-Slp4-a-IR (gray) or endogenous WPB-
MyRIP-IR (black) and WPB-EGFP FI (determined for
individual WPBs) in cells expressing EGFP-MyRIP or
EGFP-Slp4-a, respectively. In each cell (n  32, EGFP-
MyRIP; n  30, EGFP-Slp4-a), at least 15 WPBs were
quantified to determine the intensity of WPB-IR and
EGFP fluorescence. WPB-IRs were scaled to the mean
intensity of IR for each antigen in nonexpressing cells
(n  40) within the same experiment.
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in culture. HUVEC numbers and total protein content increased
with time, reaching a plateau by 96 hours (supplemental Figure
6B). As expected, levels of Proregion, adjusted for cell number,
increased progressively, whereas those of Rab27A and housekeep-
ing proteins remained unchanged (Figures 6C). Thus, HUVECs
maintain a relatively constant intracellular pool of Rab27A in the
face of large increases in the WPB pool size, consistent with
Rab27A cycling underlying the dilution of individual WPB-
Rab27A levels.
Finally, we examined how Pr changed with time after WPB
formation. We performed a morphologic pulse-chase using
Proregion-EGFP, and at specific times after nucleofection cells
were either fixed and stained for endogenous Slp4-a or MyRIP, or
used in live secretion experiments. Figure 6Di-iii shows the
increase in mean number of fluorescent WPBs per cell with time
after nucleofection (Figure 6Di), the mean percentage of these
fluorescent WPBs that were positive for Slp4-a- (F) or MyRIP-IR
(E; Figure 6Dii), and Pr (Figure 6Diii; F). The fraction of WPBs
positive for Slp4-a- or MyRIP-IR was similar at each time,
consistent with the time-dependent recruitment of Rab27A.13 At
early times, when most WPBs lacked Slp4-a- or MyRIP-IR, Pr
was low but increased to close to maximal levels as the fraction
of WPBs positive for both effectors increased. Figure 6Diii also
shows Pr values recalculated for the fraction of Slp4-a-positive
WPBs at each approximate time point (E). The data suggest that
Pr is closely linked to the WPB recruitment of both Slp4-a and
MyRIP.
Discussion
Rab proteins on WPBs: composition and recruitment
WPBs in HUVECs and HAECs recruit Rab3B and Rab3D in
addition to Rab27A. In a small number of perinuclear Rab27A-
negative (immature) WPBs, we observed detectable Rab3B-IR
(Figure 2C). Rabs are delivered to their target membranes by
1 of 2 routes: as newly synthesized Rabs in association with Rab
Figure 5. KD of Rab27A, but not of Rab3B or Rab3D,
decreases hormone-evoked VWF secretion.
(Ai-ii) Quantification of mRNA and protein after nucleofec-
tion with either control (siCTRL) or specific KD oligos as
indicated. mRNA KD were Rab3B (89%  2%), Rab27A
(92%  0.4%), Rab3B/Rab27A (81%  1%/87%  2%),
and Rab3D (87%  2.6%). Data were pooled from 3-5
independent experiments. Representative immunoblots
are shown. Position of molecular weight markers (kDa)
are shown to the right; -tubulin (Ai) or transferrin
receptor (TfR, Aii) were used as loading controls.
(Aiii) Four left panels: Immunostainings of HUVECs for
endogenous Rab3B (mouse Ab, green) or Rab27A
(mouse Ab, green) and VWF (sheep Ab, red) in control or
KDs as indicated. Two right panels: Immunostainings of
HUVECs for Rab3B (mouse Ab, green), Rab27A (rabbit
Ab, blue), and VWF (sheep Ab, red). Grayscale images
are from regions indicated by white boxes. Scale bars
represent 20 m. (Aiv) Immunostainings of HUVECs for
Slp4-a (rabbit Ab, green in color merge on left) and VWF
(sheep Ab, red in color merge on left) in control (top) or
Rab3B/Rab27AKD (bottom). Scale bars represent 20 m.
(B) Histamine-evoked VWF secretion from HUVECs
nucleofected with control or specific siRNA oligos for
Rab3B, Rab27A, or Rab3B/Rab27A (Bi), or Rab3D
(Bii) as indicated. Open bars represent control (vehicle
alone); and gray bars, histamine stimulation. Data were
pooled from 3 independent experiments. There was no
significant difference in VWF secretion between Rab27A
KD and Rab3B/Rab27A KD (P  .26). Compared with
siCTRL, basal secretion of VWF was significantly lower in
Rab27A (P  .02) or Rab27A/Rab3B (P  .015) KD
experiments.
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Escort Protein (REP),33,34 or during subsequent Rab cycling, in
association with guanine-nucleotide dissociation inhibitor (GDI).35
The key step for Rab delivery by either route is membrane insertion
that requires Rab GDP-GTP exchange catalyzed by a guanine-
nucleotide exchange factor (RabGEF, and possibly other as yet
unidentified molecules).36 Comparison of Rab3B 
recr with Rab3B

ass or 
diss (Figure 3) showed that the initial recruitment is much
slower than Rab cycling on mature WPBs, suggesting that
immature WPBs may preferentially recruit newly synthesized
Rabs. Because newly synthesized Rab3B, Rab3D, and Rab27A
share many common molecular components for delivery to
target membranes,33,34 including a RabGEF (RabGEP36), it is not
surprising that 
recr for mEGFP-Rab3B and EGFP-Rab27A to
immature WPBs were similar. However, if endogenous Rab3B
were more abundant than Rab27A at the protein level, as seen at
the transcript level, then competition between Rab3B and
Rab27A for shared molecular components could account for
Rab3B-positive Rab27A-negative WPBs. Indeed, a very low
GTPase activity for Rab27A may lend an additional competitive
advantage to Rab3B in accessing REP.37,38 Direct evidence for
competition between secretory Rabs in HUVECs came from
observations that EGFP-Rab27A or mEGFP-Rab3s’ expression
depleted endogenous WPB-Rab3B- or Rab27A-IR, respectively
(supplemental Figure 7A-B). The primary point of competition
between these Rabs is probably membrane insertion because
neither cytosolic EGFP nor YFP-Rab1A, which uses distinct
GEFs (and GTPase activating proteins),39 displaced Rab3B from
WPBs (supplemental Figure 7C).
Slp4-a recruitment to WPBs
We show that WPB recruitment of Slp4-a involves not only
Rab27A but also Rab3B (and potentially Rab3D; Figures 3E and
5Aiv), accounting for several otherwise unexpected observations:
the failure of Rab27A KD to remove Slp4-a from WPBs (supple-
mental Figure 3Eii), the presence of Slp4-a-IR on a population of
endogenous Rab27A-negative WPBs, and retention of Slp4-a-IR
on WPBs after displacement of endogenous Rab27A-IR (and
MyRIP-IR) by overexpressed EGFP-Rab3s (eg, supplemental
Figure 7D).
Photobleaching studies showed fast Rab3s cycling on indi-
vidual WPBs, consistent with previous bulk granule bleaching
studies in PC12 cells.40 Because Slp4-a binds to Rab3s only in the
GTP form (supplemental Figure 4A),15,41 the fast 
ass of EGFP-
Slp4-a with mRFP-Rab3–expressing WPBs (Figure 3E) indicates
that Slp4-a cycling is strongly influenced by the underlying cycling
of Rab3s. Rab27A also cycled, but its 
ass was very slow, consistent
with studies in PC12 cells.40 Slow Rab27A cycling could reflect the
fast constitutive GDP-GTP exchange and slow GTP hydrolysis
rates reported to hold Rab27A predominantly as GTP-Rab27A on
SGs.37 Unlike for Rab3s, conversion to GDP-Rab27A is not
associated with loss from membranes.37 Whether this arises
because Rab27A is a poor substrate for GDI or because access to
GDI is hindered by binding to effectors in the GDP-state (eg,
Slp4-a, coronin-3)41,42 remains to be established. The cycling of
EGFP-Slp4-a on mRFP-Rab27A–expressing WPBs mirrored the
very slow cycling of Rab27A itself, presumably because Slp4-a,
Figure 6. The probability of WPB exocytosis is main-
tained over a wide range of WPB-Rab27A concentra-
tions. (A) Mean intensities of WPB-IR for endogenous
Rab27A(squares), MyRIP (triangles), and Slp4-a (circles)
as a function of WPB numbers per cell. Data scaled to the
mean intensity for the 	 50 WPBs per cell. Numbers of
cells analyzed: Rab27A, 124-218; MyRIP, 17-73; Slp4-a,
16-39. For all cells with  50 WPBs, Rab27A and MyRIP
intensities of WPB-IR were significantly lower than for
cells with 	 50 WPBs (P 	 .0001 in all cases). For
Slp4-a, corresponding WPB-Slp4-a-IR differences were
not significant (P  .14). (B) Probabilities of WPB exocy-
tosis, Pr, for ionomycin or histamine stimulation as
indicated, plotted against the mean number of fluores-
cent Proregion-EGFP–containing WPBs, binned simi-
larly to panel A. Data from 17-51 (ionomycin), 15-32
(100M histamine), and 3-10 (1M histamine) cells.
(C) Quantification of Rab27A levels in HUVECs seeded
at 1.0  105 cells per 3.5-cm dish and cultured in HUVEC
growth medium for 24-120 hours. Growth media was
replaced after 72 hours. At indicated times, the cells were
counted, lysates made, and protein content determined
(supplemental Figure 6B top). The intracellular content of
Proregion (red), Rab27A (blue), -tubulin (light gray), and
actin (dark gray) at each time point was determined by
immunoblotting, band intensities quantified in ImageJ,
and corrected for cell number at corresponding time
points. Cellular protein levels are presented as a percent-
age of those at 24 hours (data from 3 experiments, each
performed in triplicate). (D) Changes in exocytosis of
Proregion-EGFP–positive WPBs with time after nucleo-
fection, same abscissa in subpanels i through iii.
(Di) Increase in mean number of fluorescent WPBs per
cell. (Dii) Mean percentage of Proregion-EGFP–positive
WPBs displaying endogenous WPB-Slp4-a-IR (F) or
WPB-MyRIP-IR (E) at the times indicated after nucleofec-
tion. (Diii) Probability of WPB exocytosis Pr for 100M
histamine stimulus (F). (E), Pr values scaled by the mean
fraction of Slp4-a–positive WPBs (from Figure 6Dii,  7,
12, 24, and 48 hours). Sixteen to 29 cells were analyzed
at each time point.
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unlike other Rabs, binds to both GTP and GDP-bound states of
Rab27A.41 The fact that EGFP-Slp4-a alone cycled as fast as in the
presence of exogenous Rab3B or Rab3D indicates that Slp4-a
associates with endogenous WPB-Rab3s in living HUVECs.
Slp4-a and MyRIP have opposite effects on WPB exocytosis
Our data show that Slp4-a acts as a positive regulator of hormone-
evoked WPB exocytosis and confirm that MyRIP is a negative
regulator of this process.14 The latter is also consistent with
MyRIP’s reported role in phorbol 12-myristate 13-acetate (PMA)–
stimulated secretion of VWF.13 The results for Slp4-a are particu-
larly interesting because this molecule is reported to be inhibitory
for SG exocytosis in other secretory cells.20,43 This inhibitory effect
is thought to arise through an increased tendency to form nonpro-
ductive docked complexes with PM syntaxins, although the
underlying kinetics of exocytosis remain unchanged. In contrast,
we found that Slp4-a expression increased Pr in response to
ionomycin and slowed the initial phase of WPB fusion. The latter
could involve the aforementioned processes,20,43 but this remains to
be established.
A striking consequence of EGFP-Slp4-a overexpression was a
reduction in the intensity of endogenous WPB-MyRIP-IR, showing
that these effectors compete for their common binding partner,
Rab27A. This raises the intriguing possibility that the increase in Pr
observed on EGFP-Slp4-a expression might arise simply from the
competitive displacement of endogeous MyRIP from GTP-
Rab27A on WPBs. Indeed, the relatively modest effect of EGFP-
Slp4-a expression (20%-25% increase in WPB exocytosis), was
reminiscent of the effect of MyRIP KD ( 15%-25% increase in
VWF secretion). Conversely, EGFP-MyRIP expression should
displace endogenous Slp4-a from GTP-Rab27A bound to WPBs,
shifting the occupancy of GTP-Rab27A toward MyRIP and thus
inhibiting WPB exocytosis. Indeed, we observed a complete
inhibition of WPB exocytosis, although depletion of endogenous
Slp4-a-IR from WPBs was masked by the capacity of WPB-Rab3s
to recruit Slp4-a to WPBs. Compared with the relatively small
effect of MyRIP depletion from WPBs, it indicates that endogenous
WPB-MyRIP levels exert a relatively weak brake on WPB
exocytosis.
Rab27A regulates VWF secretion
Rab27A KD caused a significant inhibition of both unstimulated
and stimulated VWF secretion, whereas Rab3B or Rab3D
depletion had no effect (Figure 5B). A reduction in unstimulated
secretion in other KD conditions (eg, Slp4-a) also mirrored the
effect on stimulated secretion. Because the majority of unstimu-
lated VWF secretion arises from basal release of WPBs,44 this
indicates that the same molecular machinery influences stimu-
lated and basal VWF secretion. Our Rab27A KD data differ
from a previous study reporting a substantial increase in
PMA-stimulated VWF secretion,13 presumably reflecting differ-
ences in the mechanisms by which PMA and hormone trigger
VWF secretion. An increase in histamine-evoked VWF secre-
tion was also reported in that study13; however, those results
were equivocal because of a 3-fold increase in unstimulated
VWF release caused by Rab27A KD.
Overexpression of epitope-tagged Rab3D has also been re-
ported to inhibit hormone-evoked VWF secretion,3 and we ob-
served the same result (supplemental Figure 7E). However, we
found that Rab3D overexpression was accompanied by loss of
endogenous WPB-Rab27A-IR and MyRIP-IR (supplemental Fig-
ure 7Bii), although WPB-Slp4-a-IR was still observed, consistent
with Slp4-a binding to WPB-Rab3s (supplemental Figure 7D). The
data suggest that the effect of Rab3D overexpression arises through
Figure 7. Slp4-a and MyRIP acting via Rab27A control
the probability of WPB exocytosis independently of
WPB pool size. (A) Rab27A cycles between the cytosol
and the WPB membrane, a process thought to be
dependent on GDP-dissociation inhibitor (GDI; rectangu-
lar insert, cellular components are not drawn to scale).
Rab cycling distributes Rab27A approximately evenly
between all WPBs within the cell. Because the cellular
content of Rab27A remains constant in culture, increases
in WPB pool size (gray gradient) over a “Physiologic
range” (beige bar) result in a decrease in the amount of
Rab27A on individual WPBs (purple gradient). The prob-
ability of WPB release (Pr, dashed line) remains constant
over this “Physiologic range” of WPB pool sizes, indicat-
ing that the control of WPB exocytosis cannot solely
depend on the absolute amount of WPB-Rab27A. As
long as the cellular content of Rab27A (and its effectors)
remains constant, the steady-state fractional occupancy
of Rab27A by its effectors will also be constant, irrespec-
tive of the absolute Rab27A concentration on individual
WPBs. This raises the possibility that the fractional
occupancy of Rab27A by its effectors, rather than just the
absolute amount of these molecules, sets the Pr. Substan-
tial depletion (by KD, extreme right of panel A) or high
overexpression (OE, extreme left in panel A; data not
shown) of Rab27A results in a reduction in Pr. (B) WPB
exocytosis is determined by the balance of occupancy of
WPB-Rab27A by negative (MyRIP that binds only GTP-
Rab27A) and positive (Slp4-a that binds both GTP- and
GDP-Rab27A) effectors. Manipulations that alter either
effector concentration or cellular Rab27A levels can
perturb the fractional occupancy of WPB-Rab27A by its
effectors, resulting in changes (small vertical arrows) in
the probability of WPB exocytosis.
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competitive displacement of Rab27A from WPBs and that, despite
recruiting Slp4-a to WPBs, Rab3s do not support the positive action
of Slp4-a on VWF secretion. The latter idea is consistent with
previous data in PC12 cells.21 Slp4-a binds to GTP- and GDP-
Rab27A states,41 whereas MyRIP binds to GTP-Rab27A only.45 If
Slp4-a and MyRIP compete for WPB-Rab27A, as suggested by
data in Figure 4Civ, then the capacity of Slp4-a to bind GDP-
Rab27A could confer a competitive advantage over MyRIP in a
positive drive toward exocytosis.
KD of Rab3B (and Rab3D) suggests little or no role for these
Rabs in controlling WPB exocytosis, raising the intriguing question
as to their function on the WPBs. Rab3B and Rab3D are implicated
in processes not directly related to control of exocytosis, including
the regulation of catecholamine uptake into SGs,46 receptor transcy-
tosis,47 SG-microtubule interactions,48 and SG maturation.49 The
function of Rab3s on WPBs remains to be established.
The probability of WPB exocytosis does not depend solely on
the absolute WPB-Rab27A concentration over the endogenous
range
Despite marked intercellular variations in the amount of endoge-
nous Rab27A (and MyRIP) on WPBs because of increasing WPB
pool size (Figures 1B and 6A; supplemental Figure 3A-B), Pr was
constant for a given stimulus strength (Figure 6B). This suggests
that Pr is not determined solely by the absolute amount of Rab27A
and its effectors on WPBs, although some finite amount of each
must be required. Instead, some other parameter(s) must be
important in determining Pr. We found that the total cellular
content of Rab27A remains essentially constant with time in
culture, and our preliminary results indicate that the same is true for
MyRIP and Slp4-a (and Rab3B). In this case, the steady-state
fractional occupancy of Rab27A by its effectors should also remain
constant, irrespective of the absolute amounts of Rab27A on any
individual organelle. This raises the possibility that the fractions of
WPB-Rab27A molecules occupied by MyRIP and Slp4-a are the
crucial factor in determining Pr. Most newly formed WPBs lack
endogenous Slp4-a-IR, MyRIP-IR (Figure 6Dii), Rab27A-IR12
(and Rab3B-IR, Figure 2B), and for these organelles Pr was very
low (Figure 6Diii). The close correlation between the increase in Pr
(Figure 6Diii) and increase in the fraction of WPBs with detectable
Slp4-a- and MyRIP-IR (Figure 6Dii) shows that the capacity to
undergo exocytosis is closely linked to acquisition of both effector
molecules. By assuming that WPBs completely lacking these
components are not fusion-competent, we found that newly formed
WPBs (7 hours after nucleofection) with detectable Slp4-a-IR and
MyRIP-IR had a Pr not much lower than that seen for much older
organelles (Figure 6Diii, E). The slightly higher Pr seen for older
WPBs may reflect their predominantly peripheral localization and
closer apposition to the PM. Manipulations that alter the steady-
state fractional occupancy of Rab27A (eg, overexpression or KD of
Slp4-a or MyRIP) change Pr and VWF secretion. Substantial
reductions in WPB-Rab27A levels after Rab27A KD simulate a
return toward the “immature state” where Rab27A, MyRIP, and
Slp4-a are missing, rendering WPBs less responsive to stimulation.
In conclusion, WPBs recruit multiple Rabs; however, our data
suggest that Slp4-a and MyRIP acting via Rab27A regulate WPB
exocytosis and VWF secretion. Our data indicate that the fractional
occupancy of WPB-Rab27A by its effectors rather than just the
absolute amount of these molecules on WPBs is an important factor
in determining Pr. Thus, by simply maintaining the cellular content
of Rab27A and its effectors at approximately constant levels, ECs
maintain Pr constant irrespective of WPB pool size (Figure 7). This
provides a simple mechanism to ensure a coordinated and propor-
tionate response of the EC population to external stimuli of varying
intensity.
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